Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control.

Multinational eye care major Alcon is preparing to roll out multiple products in India over the coming months, in response to growing demand for advanced ophthalmic technologies and a strategic ...

Analysts use this formula to calculate it for Alcon: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.049 = US$1.4b ÷ (US$30b - US$2 ...

Our study demonstrated that PCP had higher complete success rate and survival rates at 12, 18, and 24 months than phaco alone (Figure 1). Although the PCP group had lower VA than the phaco group ...

The main portion of employees (over 60,000) worked in pharmaceuticals – the company's main focus – while the rest are split between Alcon, Sandoz, Vaccines and Diagnostics, Consumer Health ...

At close: April 17 at 5:31:31 p.m. GMT+2 ...

At close: 17 April at 16:00:02 GMT-4 ...

VTIP Vanguard Short-Term Inflation-Protected Securities Index Fund ETF Shares ...

Simulation Surgeon. Cataract surgery mentor with active learning and simulation ...